Huijben Silvie, Paaijmans Krijn P
ISGlobal Barcelona Ctr. Int. Health Res. (CRESIB) Hospital Clínic - Universitat de Barcelona Barcelona Spain.
Centro de Investigação em Saúde de Manhiça Maputo Mozambique.
Evol Appl. 2017 Nov 6;11(4):415-430. doi: 10.1111/eva.12530. eCollection 2018 Apr.
Since 2000, the world has made significant progress in reducing malaria morbidity and mortality, and several countries in Africa, South America and South-East Asia are working hard to eliminate the disease. These elimination efforts continue to rely heavily on antimalarial drugs and insecticide-based interventions, which remain the cornerstones of malaria treatment and prevention. However, resistance has emerged against nearly every antimalarial drug and insecticide that is available. In this review we discuss the evolutionary consequences of the way we currently implement antimalarial interventions, which is leading to resistance and may ultimately lead to control failure, but also how evolutionary principles can be applied to extend the lifespan of current and novel interventions. A greater understanding of the general evolutionary principles that are at the core of emerging resistance is urgently needed if we are to develop improved resistance management strategies with the ultimate goal to achieve a malaria-free world.
自2000年以来,全球在降低疟疾发病率和死亡率方面取得了重大进展,非洲、南美洲和东南亚的几个国家正在努力消除这种疾病。这些消除疟疾的努力仍然严重依赖抗疟药物和基于杀虫剂的干预措施,这些措施仍然是疟疾治疗和预防的基石。然而,几乎所有现有的抗疟药物和杀虫剂都出现了耐药性。在这篇综述中,我们讨论了我们目前实施抗疟干预措施的方式所产生的进化后果,这种方式正在导致耐药性,最终可能导致防控失败,同时也讨论了如何应用进化原理来延长现有和新型干预措施的使用寿命。如果我们要制定更好的耐药性管理策略,最终目标是实现无疟疾世界,那么迫切需要更深入地了解导致耐药性出现的核心一般进化原理。